[HTML][HTML] In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro)

VA Falade, TI Adelusi, IO Adedotun… - In Silico …, 2021 - Springer
It is no longer news that a novel strain of coronavirus named SARS-CoV-2 is ravaging the
health sector worldwide, several attempts have been made to curtail this pandemic via …

[HTML][HTML] In silico bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19

S Mujwar, RK Harwansh - Structural Chemistry, 2022 - Springer
COVID-19 was caused by a novel coronavirus known as SARS-CoV-2. The COVID-19
disease outbreak has been avowed as a global pandemic by the World Health Organization …

[HTML][HTML] Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): In-silico evidences

RR Narkhede, AV Pise, RS Cheke… - Natural products and …, 2020 - Springer
Abstract SARS-CoV-2 (2019-nCoV) emerged in 2019 and proliferated rapidly across the
globe. Scientists are attempting to investigate antivirals specific to COVID-19 treatment. The …

[HTML][HTML] In silico investigation of ACE2 and the main protease of SARS-CoV-2 with phytochemicals from Myristica fragrans (Houtt.) for the discovery of a novel COVID …

T Ongtanasup, S Wanmasae, S Srisang… - Saudi Journal of …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes
coronavirus disease 2019 (COVID-19), is a new coronavirus strain that was first reported in …

Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants–Emblica officinalis (Amla), Phyllanthus niruri Linn …

S Murugesan, S Kottekad, I Crasta… - Computers in biology …, 2021 - Elsevier
Abstract Coronavirus Disease-2019 (COVID-19), a viral disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) was declared a global pandemic by …

[HTML][HTML] In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

SK Chidambaram, D Ali, S Alarifi… - Journal of Infection and …, 2020 - Elsevier
Background The unique anthropological coronavirus which has been titled as SARS-CoV-2
was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as …

[HTML][HTML] In silico evaluation of Iranian medicinal plant phytoconstituents as inhibitors against main protease and the receptor-binding domain of SARS-CoV-2

SS Mousavi, A Karami, TM Haghighi, SG Tumilaar… - Molecules, 2021 - mdpi.com
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), which initially appeared in Wuhan, China, in …

In-silico strategies of some selected phytoconstituents from Melissa officinalis as SARS CoV-2 main protease and spike protein (COVID-19) inhibitors

D Prasanth, M Murahari, V Chandramohan… - Molecular …, 2021 - Taylor & Francis
Melissa officinalis (Lamiaceae) was used to treat multiple human afflictions. Literary works
demonstrated that it has many biological activities. Today's research aims to recognise …

[HTML][HTML] Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach

P Rangsinth, C Sillapachaiyaporn, S Nilkhet… - Journal of traditional and …, 2021 - Elsevier
Abstract Background and aim Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19

Ş Adem, V Eyupoglu, IM Ibrahim, I Sarfraz… - Computers in biology …, 2022 - Elsevier
Abstract SARS-CoV-2, a rapidly spreading new strain of human coronavirus, has affected
almost all the countries around the world. The lack of specific drugs against SARS-CoV-2 is …